Navigation Links
Derma Sciences Expands Direct Sales Force for Advanced Wound Care, Looks to Double Again in 2008
Date:1/18/2008

PRINCETON, N.J., Jan. 18 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (OTC Bulletin Board: DSCI), a provider of advanced wound care products, said that it has increased its direct-sales staff significantly, based on a number of new products that are finding favor in target markets. The company, which had only two direct salespersons in the US a year ago, now has nine, and will move to 21 by 2009. The increase is a significant one for Derma Sciences, which has been growing sales at an accelerating rate, and which has introduced several new products over the last couple of years. Most recently, the company launched MEDIHONEY(TM) Calcium Alginate with Active Leptospermum Honey. This product, along with several line extensions to be launched in 2008, is covered under several patents.

Chairman and CEO Ed Quilty commented, "MEDIHONEY has made quite a stir since we introduced it a few months back, and we are looking forward to it as a strong lead product for the sales force. Expanding our sales force allows us to maximize the opportunity, and also broadens the coverage of our entire product line of advanced wound-care products. We will be detailing wound-care centers, nursing homes, hospitals and medical specialists.

"We are not a giant corporation, but we believe strongly in our products, and we know that they improve quality of life for patients, and make better patient care possible for caregivers," Quilty added. "At this time next year, we will be covering all of the United States and Canada with our own sales force. It is a very exciting time for Derma Sciences."

Quilty said that with its own world-class manufacturing in China and Canada, Derma Sciences is poised to become a significant niche supplier to the advanced wound-care market, particularly targeting wounds that are difficult to heal, such as pressure ulcers (bedsores), venous ulcers and diabetic leg ulcers, conditions that are becoming more common as the baby boom generation ages.

The company intends to hire during the remainder of 2008 12 additional salespersons and 3 wound-care certified nurses who specialize in in-service training, according to Bob Cole, Senior VP of Sales. "This broader coverage will help meet current and anticipated demand for the company's advanced wound-care products; if all goes well, the expansion could continue in 2009, especially as our R&D has been filling our product pipeline with additional cutting-edge products."

MEDIHONEY is the first honey-based product marketed in the US for advanced wound care, although similar products have been marketed in the UK and Europe for some time. It is comprised primarily of active Leptospermum honey, which is noted for its effects on wound healing and burn management. Derma Sciences also supplies products such as the antimicrobial silver-based ALGICELL(TM) Ag and a variety of additional proprietary wound-healing products.

About Derma Sciences

Derma Sciences is a manufacturer and marketer of advanced wound-care products, with operations based in the US and Canada, and sales worldwide. The company sources Active Manuka (Leptospermum scoparium) Honey from Comvita New Zealand, Ltd. Comvita controls over 70% of the flow of manuka honey, and owns several patents around the use of honey in wound dressings. The Company has also obtained FDA clearance to market and sell its MOBILITY-1(TM) boot and compressor device for the treatment of venous ulcers, lymphedema, and other conditions that require compression therapy. For more information about Derma Sciences, Inc., visit its home page on the Internet at http://www.dermasciences.com.

Forward-looking Statements

Statements contained in this release that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the generality of the foregoing, words such as "may," "will," "expect," "believe," "anticipate," "intend," "could," "estimate" or "continue" are intended to identify forward-looking statements. Readers are cautioned, that certain important factors may affect the Company's actual results and could cause such results to differ materially from any forward-looking statements which may be made in this release or which are otherwise made by or on behalf of the Company. Factors which may affect the Company's results include, but are not limited to, product demand, market acceptance, impact of competitive products and prices, product development, completion of an acquisition, commercialization or technological difficulties, the success or failure of negotiations and trade, legal, social and economic risks. Additional factors that could cause or contribute to differences between the Company's actual results and forward-looking statements Include but are not limited to, those discussed in the Company's filings with the Securities and Exchange Commission.

Contact:

Allen & Caron Derma Sciences

(212) 691-8087 609-514-4744

Rudy Barrio (US Investors) Edward J. Quilty

r.barrio@allencaron.com Chairman and CEO

equilty@dermasciences.com

Brian Kennedy (Media)

brian@allencaron.com


'/>"/>
SOURCE Derma Sciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Actavis Receives Approval of Fentanyl Transdermal System in the U.S.
2. Avicena Signs Worldwide Exclusive Distribution Agreement with RITA Corporation for its Proprietary Dermaceutical Compounds
3. AGI Dermatics President to be Keynote Speaker at the 11th Annual Sunscreen Symposium
4. Carrington Subsidiary DelSite Biotechnologies Enters into Technology Evaluation Rights License Agreement for Transdermal Delivery of Vaccines
5. Government Expands Trial With IMVAMUNE(R) Smallpox Vaccine in Persons With Atopic Dermatitis/Eczema
6. Ferndale and Foamix Enter Development of an Innovative Foam for the Treatment of Atopic Dermatitis
7. Phosphagenics Announces Successful Phase 1 Transdermal Oxycodone Clinical Trial Results
8. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
9. Selection of Development Candidate Triggers $0.5 Million Milestone Payment to Ardea Biosciences, Inc.
10. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
11. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2017)... , May 23, 2017 As Ebola resurfaces ... with four deaths and 20 suspected cases now reported, a ... the PubMed database, showed a correlation between the 2014 and ... Replikin counts rose sharply in 2012-13, which preceded the 2014 ... in the Ebola gene Replikin counts in 2014-15, which again ...
(Date:5/23/2017)... (PRWEB) , ... May 23, ... ... offer an unlimited source of human cardiovascular cells for research and the ... methods makes it possible to generate large numbers of cardiomyocytes (hPSC-CMs). Due ...
(Date:5/23/2017)... Washington, USA (PRWEB) , ... May 22, 2017 ... ... SPIE Optics and Photonics 2017 in San Diego, California, this August will ... reality, solar fuels, and autonomous vehicles. , SPIE Optics and Photonics, the largest ...
(Date:5/23/2017)... ... 23, 2017 , ... Kathy Goin is joining myClin ... brings years of expertise in establishing and leading clinical operations at Sponsors including ... occupational therapist, through a variety of leadership roles in Clinical Operations, to her ...
Breaking Biology Technology:
(Date:3/27/2017)... 2017  Catholic Health Services (CHS) has been ... (HIMSS) Analytics for achieving Stage 6 on the ... In addition, CHS previously earned a place in ... electronic medical record (EMR). "HIMSS Analytics ... EMR usage in an outpatient setting.  This recognition ...
(Date:3/23/2017)... Research and Markets has announced the addition of the "Global ... 2025" report to their offering. ... The Global Vehicle Anti-Theft System Market is ... next decade to reach approximately $14.21 billion by 2025. ... all the given segments on global as well as regional levels ...
(Date:3/20/2017)... March 20, 2017 At this year,s CeBIT Chancellor ... biometrics manufacturer DERMALOG. The Chancellor came to the DERMALOG stand together with ... this year,s CeBIT partner country. At the largest German biometrics company the ... fingerprint, face and iris recognition as well as DERMALOGĀ“s multi-biometrics system.   ... ...
Breaking Biology News(10 mins):